Oncology & Liquid Biopsy Biomarker
This section welcomes research on circulating biomarkers relevant to cancer detection, progression, prognosis, and treatment monitoring. Areas include circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles, tumor‑derived proteins, liquid biopsy technologies, and biomarkers for minimal residual disease or therapy response. Both discovery‑focused and clinically oriented studies are included.
Associate Editor: Prof. Roger Chammas
| Ongoing call for papers



